Abstract
Real-world evaluation of effectiveness and safety of cladribine tablets and patient reported outcomes in suboptimally controlled patients previously taking oral or intravenous disease-modifying drugs for relapsing forms of multiple sclerosis (MASTER-2) (4242)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
